Sign In
Buy UN
$60.50
+0 (+0%)
At Close: Dec 08, 2021
Why Unilever Stock Tanked 10% at the Open Today
11:05am, Tuesday, 18'th Jan 2022
Shares of the consumer goods giant dropped as investors digested a failed attempt to buy its way into the healthcare niche.
Unilever is not giving up on GSK's consumer business
02:24pm, Monday, 17'th Jan 2022
Shares of Unilever plc (LON: ULVR) slid 4.0% on Monday after the British multinational said it was still interested in buying GlaxoSmithKline plc's (LON: GSK) consumer business. GSK continues to rejec
GlaxoSmithKline Says 'No' 3 Times
12:53pm, Monday, 17'th Jan 2022
Executives at GlaxoSmithKline PLC ( GSK , Financial) confirmed on Saturday that they had received three unsolicited, conditional and non-binding proposals from Unilever PLC to acquire the GalxoSmithKl
Unilever's offer for GSK's consumer health raises doubts, questions over strategy
10:34am, Monday, 17'th Jan 2022
Unilever faces a dilemma after its 50 billion pound ($68 billion) offer for GlaxoSmithKline's consumer healthcare assets was rejected -- should it raise the bid and risk overpaying or seek another rou
Unilever yet to demonstrate it would be the right owner of GSK's Consumer Healthcare division
09:24am, Monday, 17'th Jan 2022
Has there ever been a time in the last 50 years when investors and Unilever PLC (LSE:ULVR) management alike were not concerned about sluggish growth? With brands such as (deep breath) Hellmann's, Vase
GlaxoSmithKline shares rise after it rejects Unilever bid for its consumer healthcare division
03:50am, Monday, 17'th Jan 2022
GlaxoSmithKline PLC (LSE:GSK) said the £50bn offer by Unilever PLC (LSE:ULVR) for its Consumer Healthcare business fundamentally undervalues the business. Unilever made three unsolicited approaches t
Unilever PLC (LSE:ULVR) has confirmed that it had a bid for GlaxoSmithKline's consumer healthcare business rebuffed. GlaxoSmithKline PLC (LSE:GSK) (GSK) revealed yesterday that it knocked back three a
Unilever says GSK consumer arm 'strong strategic fit' for business
02:55am, Monday, 17'th Jan 2022
(Reuters) -Dove soap maker Unilever signalled on Monday it would pursue a deal for GlaxoSmithKline's consumer health business, calling it a "strong strategic fit" after its 50-billion-pound approach (
GlaxoSmithKline, Unilever Spar Over Future of GSK's Consumer Health Business
11:10pm, Sunday, 16'th Jan 2022
GlaxoSmithKline and Pfizer will hold out for a better bid of at least £60 billion for their joint consumer healthcare venture, in opposition to an earlier offer they didn't like, Financial Times writ
Unilever to weigh raising offer for Glaxo Consumer unit - Bloomberg
03:37pm, Sunday, 16'th Jan 2022
Unilever Plc has held talks with banks about additional financing for a potential sweetened offer for GlaxoSmithKline Plc's consumer products division, Bloomberg reported on Sunday, citing people fami
GSK Spurns $68.4B Bid From Unilever For Its Consumer Healthcare Business, Opts to Spin-off The Unit
02:17pm, Saturday, 15'th Jan 2022
GlaxoSmithKline rejects three purchase offers from Unilever for its Consumer Healthcare business. The U.K. pharma giant says the business is well-positioned to sustainably grow ahead of its categori
GlaxoSmithKline Rejects Unilever Offer for its Consumer Health Unit
01:30pm, Saturday, 15'th Jan 2022
Glaxo says Unilever has made three proposals to buy the GSK Consumer Healthcare business. Its most recent approach in December was for 50 billion pounds ($68.4 billion).
Unilever offers 50 billion pounds for GSK unit -report
05:40am, Saturday, 15'th Jan 2022
Consumer goods giant Unilever has made a bid for pharmaceutical group Glaxosmithkline's consumer goods business worth roughly 50 billion pounds ($68.4 billion), Britain's Sunday Times reported.
Unilever: Caution Reflected In Lagging Returns
06:45am, Friday, 14'th Jan 2022
Unilever is the company behind well-known consumer good brands such as Cif, Knorr, Hellmann's, and Lifebuoy.
Unilever: Profit Vs. Sustainability
01:34pm, Thursday, 13'th Jan 2022
Unilever has been blamed for 'losing the plot' and its management publicly displaying its sustainability credentials at the expense of running the business. Performance during the last couple of years
